Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma studyWeili Sun, James A. Whitlock, Jemily Malvar et al.|Leukemia|2018Cited by 117
Myeloid lineage switch following chimeric antigen receptor T‐cell therapy in a patient with TCF3‐ZNF384 fusion‐positive B‐lymphoblastic leukemiaMatthew J. Oberley, Gordana Raca, Paul S. Gaynon et al.|Pediatric Blood & Cancer|2018Cited by 104
Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal AntibodiesHema Dave, Christoph Rader, Miriam R. Anver et al.|PLoS ONE|2012Cited by 53
Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot StudyMichael J. Burke, Patrick A. Brown, Min-Jung Lee et al.|Clinical Cancer Research|2020Cited by 45
Treatment‐related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemiaWeili Sun, Alan S. Wayne, Etan Orgel et al.|Pediatric Blood & Cancer|2016Cited by 29